{"id":"https://openalex.org/W2123758151","doi":"https://doi.org/10.1634/theoncologist.7-2-126","title":"Comparable Efficacy of Epoetin Alfa for Anemic Cancer Patients Receiving Platinum- and Nonplatinum-Based Chemotherapy: A Retrospective Subanalysis of Two Large, Community-Based Trials","display_name":"Comparable Efficacy of Epoetin Alfa for Anemic Cancer Patients Receiving Platinum- and Nonplatinum-Based Chemotherapy: A Retrospective Subanalysis of Two Large, Community-Based Trials","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2123758151","doi":"https://doi.org/10.1634/theoncologist.7-2-126","mag":"2123758151","pmid":"https://pubmed.ncbi.nlm.nih.gov/11961196"},"language":"en","primary_location":{"id":"doi:10.1634/theoncologist.7-2-126","doi":"https://doi.org/10.1634/theoncologist.7-2-126","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.7-2-126","pdf_url":"https://academic.oup.com/oncolo/article-pdf/7/2/126/41838530/oncolo_7_2_126.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/oncolo/article-pdf/7/2/126/41838530/oncolo_7_2_126.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Glaspy","raw_affiliation_strings":["PROCRIT Study Group","University of California Los Angeles, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PROCRIT Study Group","institution_ids":[]},{"raw_affiliation_string":"University of California Los Angeles, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110965363","display_name":"Laurent Degos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Degos","raw_affiliation_strings":["H\u00f4pital Saint Louis, University of Paris, Paris, France","PROCRIT Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Saint Louis, University of Paris, Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210144610"]},{"raw_affiliation_string":"PROCRIT Study Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109328326","display_name":"Mario A. Dicato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162487826","display_name":"Centre Hospitalier de Luxembourg","ror":"https://ror.org/03xq7w797","country_code":"LU","type":"healthcare","lineage":["https://openalex.org/I162487826"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Mario Dicato","raw_affiliation_strings":["Centre University and Luxembourg Medical Centre, Luxembourg","PROCRIT Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre University and Luxembourg Medical Centre, Luxembourg","institution_ids":["https://openalex.org/I162487826"]},{"raw_affiliation_string":"PROCRIT Study Group","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060580923","display_name":"George D. Demetri","orcid":"https://orcid.org/0000-0002-0045-4809","observed_orcids":["https://orcid.org/0000-0002-0045-4809"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George D. Demetri","raw_affiliation_strings":["Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA","PROCRIT Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"PROCRIT Study Group","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5060580923"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":3852,"currency":"USD","value_usd":3852},"apc_paid":null,"fwci":1.2274,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.80353788,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"2","first_page":"126","last_page":"135"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.9039999842643738},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.925000011920929},{"id":"https://openalex.org/keywords/cancer-related-anemia","display_name":"cancer-related anemia","score":0.8080000281333923},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.8659999966621399},{"id":"https://openalex.org/keywords/transfusion-requirements","display_name":"transfusion requirements","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.8529999852180481},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9919999837875366},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.765999972820282},{"id":"https://openalex.org/keywords/community-trial","display_name":"community-based trial","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9259123802185059},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.7410991191864014},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6691543459892273},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5807809829711914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5385012030601501},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5272045731544495},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5115650296211243},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4774892032146454},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3781794011592865},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34554725885391235}],"mesh":[{"descriptor_ui":"D000068817","descriptor_name":"Epoetin Alfa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D001803","descriptor_name":"Blood Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010984","descriptor_name":"Platinum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1634/theoncologist.7-2-126","doi":"https://doi.org/10.1634/theoncologist.7-2-126","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.7-2-126","pdf_url":"https://academic.oup.com/oncolo/article-pdf/7/2/126/41838530/oncolo_7_2_126.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmid:11961196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11961196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.497.8004","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.497.8004","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://intl-theoncologist.alphamedpress.org/content/7/2/126.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.500.2582","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.500.2582","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://theoncologist.alphamedpress.org/content/7/2/126.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1634/theoncologist.7-2-126","doi":"https://doi.org/10.1634/theoncologist.7-2-126","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.7-2-126","pdf_url":"https://academic.oup.com/oncolo/article-pdf/7/2/126/41838530/oncolo_7_2_126.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2123758151.pdf","grobid_xml":"https://content.openalex.org/works/W2123758151.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W181963661","https://openalex.org/W182335423","https://openalex.org/W281780641","https://openalex.org/W1821554592","https://openalex.org/W1867073577","https://openalex.org/W1884165293","https://openalex.org/W1885881044","https://openalex.org/W1920419572","https://openalex.org/W2015276413","https://openalex.org/W2090741998","https://openalex.org/W2094963379","https://openalex.org/W2110612111","https://openalex.org/W2120940824","https://openalex.org/W2123365739","https://openalex.org/W2151593500","https://openalex.org/W2163830215","https://openalex.org/W2220352889","https://openalex.org/W2329804409","https://openalex.org/W2809754341","https://openalex.org/W2992010020"],"related_works":["https://openalex.org/W1885881044","https://openalex.org/W2046062792","https://openalex.org/W2007650666","https://openalex.org/W2069764585","https://openalex.org/W96159034","https://openalex.org/W2605146374","https://openalex.org/W2138416329","https://openalex.org/W2050025617","https://openalex.org/W2097622384","https://openalex.org/W2083606633"],"abstract_inverted_index":{"Abstract":[0],"Learning":[1],"Objectives":[2],"After":[3],"completing":[4],"this":[5,199],"course,":[6],"the":[7,14,29,33,69,95,218,221,273,334],"reader":[8],"will":[9],"be":[10],"able":[11],"to:":[12],"Understand":[13],"etiology,":[15],"symptoms,":[16],"and":[17,25,45,67,73,125,167,192,233,262,287,327],"impact":[18],"(as":[19],"reported":[20],"by":[21,272,281],"patients)":[22],"of":[23,35,77,97,169,174,177,217,220,239,266,284,304,309,332],"cancer-":[24],"chemotherapy-associated":[26],"anemia.":[27],"Recognize":[28],"clinical":[30,91,112],"evidence":[31],"supporting":[32],"efficacy":[34,96],"epoetin":[36,64,98,129,314],"alfa":[37,99,130,296,315],"in":[38,48,100,161,215,227,244,293,300,317,320,324,329],"reducing":[39],"transfusion":[40,162,228,321],"requirements,":[41,163,322],"increasing":[42],"hemoglobin":[43,164],"levels,":[44,166,326],"improving":[46],"quality-of-life":[47],"anemic":[49,101,310],"cancer":[50,102,311],"patients":[51,103,179,312],"receiving":[52,104],"platinum-":[53,121,337],"versus":[54],"nonplatinum-based":[55],"chemotherapy.":[56],"Identify":[57],"potential":[58],"prognostic":[59],"factors":[60],"for":[61,153,198],"responsiveness":[62],"to":[63,109,249,256],"alfa.":[65],"Access":[66],"take":[68],"CME":[70],"test":[71],"online":[72],"receive":[74],"one":[75],"hour":[76],"AMA":[78],"PRA":[79],"category":[80],"1":[81],"credit":[82],"at":[83],"CME.TheOncologist.com":[84],"Background.":[85],"Data":[86],"from":[87,247,253],"two":[88,222],"large,":[89],"community-based":[90],"trials":[92],"that":[93],"evaluated":[94],"chemotherapy":[105,119,191,224,240,267,285,305,335],"were":[106,114,159,196,207,213,236,263,289],"retrospectively":[107],"analyzed":[108],"determine":[110],"if":[111],"outcomes":[113],"different":[115,223],"depending":[116],"on":[117],"whether":[118,333],"was":[120,297],"or":[122,139,338],"nonplatinum-based.":[123,339],"Patients":[124,127],"Methods.":[126],"received":[128,190],"150-300":[131],"IU/kg":[132],"(Glaspy:":[133],"Study":[134,143],"1;":[135],"n":[136,145,181,185],"=":[137,146,182,186],"2,342)":[138],"10,000-20,000":[140],"IU":[141],"(Demetri:":[142],"2;":[144],"2,370)":[147],"s.c.":[148],"three":[149],"times":[150],"each":[151],"week":[152],"4":[154,234],"months.":[155],"Efficacy":[156],"end":[157],"points":[158],"changes":[160],"(Hb)":[165],"quality":[168],"life":[170],"(QOL).":[171],"A":[172],"total":[173],"4,298":[175],"out":[176],"4,712":[178],"(platinum-based,":[180],"1,601;":[183],"nonplatinum-based,":[184],"2,697),":[187],"who":[188],"both":[189,301],"had":[193],"available":[194],"data,":[195],"eligible":[197],"retrospective":[200],"analysis.":[201],"Results.":[202],"Baseline":[203],"characteristics":[204,219],"across":[205,259],"groups":[206,261],"comparable":[208],"with":[209,291,313],"few":[210],"exceptions,":[211],"which":[212],"anticipated":[214],"view":[216],"types.":[225],"Decreases":[226],"requirements":[229],"after":[230],"2,":[231],"3,":[232],"months":[235],"significant,":[237,264],"regardless":[238,265,283,303,331],"type.":[241,268,306],"Mean":[242],"increases":[243,292],"Hb":[245,325],"level":[246],"baseline":[248],"final":[250],"evaluation":[251],"ranged":[252],"1.6":[254],"g/dl":[255,258],"2.0":[257],"study":[260],"QOL,":[269,330],"as":[270],"measured":[271],"Linear":[274],"Analog":[275],"Scale":[276],"Assessment":[277],"(LASA),":[278],"improved":[279],"significantly":[280],"20%-43%,":[282],"type,":[286],"improvements":[288,328],"associated":[290],"Hb.":[294],"Epoetin":[295],"well":[298],"tolerated":[299],"studies,":[302],"Conclusion.":[307],"Treatment":[308],"results":[316],"significant":[318],"reduction":[319],"increase":[323],"is":[336]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}